
Suven Life Sciences (SUVEN) Share Price Falls 5.15% as Mid Cap Trades at Rs 290
Updated: 8 Oct 2026 • 1:10 pm
Posted by:

Suven Life Sciences Share Price fell 5.15% today and last traded at Rs 290, with market capitalisation at Rs 8,741.08 crore. The move took Suven Life Sciences Share Price below the previous close of Rs 305.75 and placed Suven Life Sciences in the Mid Cap category for company-size context. The price move is confirmed in Univest data; a company-specific reason has not been established. That makes Suven Life Sciences Share Price relevant as a price-action event first, and a fundamentals-led stock analysis next. For readers tracking Suven Life Sciences Share Price Today, the combination of a decline, a low day range and a premium valuation profile against the sector backdrop is the key context. Univest data also shows that Suven Life Sciences Stock News today is about the move itself, not a fresh operational disclosure.
Suven Life Sciences (SUVEN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 290 |
| Previous Close | Rs 305.75 |
| Today's Move | -Rs 15.75 (-5.15%) |
| Open | Rs 308.75 |
| High | Rs 308.75 |
| Low | Rs 288.5 |
| Market Capitalisation | Rs 8,741.08 crore |
| Market Cap Category | Mid Cap |
Suven Life Sciences Share Price Today showed a clear intraday down move. The stock opened at Rs 308.75, matched the day’s high at Rs 308.75, touched a low of Rs 288.5 and last traded at Rs 290. The day change was Rs -15.75, which translates into a 5.15% decline from the previous close of Rs 305.75. Market capitalisation stood at Rs 8,741.For Suven Life Sciences Share Price watchers, the price action shows a gap between the opening level and the later trade, but the facts on their own do not establish a cause. As of 08 October 2026 at 12:52:50 PM IST, Suven Life Sciences Share Price was trading near the lower end of the day’s range, so the next natural step is to read the valuation and operating ratios alongside the move.
Suven Life Sciences (SUVEN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 8,741.08 crore |
| P/B Ratio | 15.51x |
| ROE | -101.8% |
| ROCE | -78.71% |
| EPS | Rs -12.47 |
| Book Value Per Share | Rs 19.71 |
| Dividend Yield | 0% |
Suven Life Sciences (SUVEN) fundamental metrics show P/B 15.51x, ROE -101.8%, ROCE -78.71%. These ratios show where the company stands today and are not a call to buy or sell.
Suven Life Sciences has a market capitalisation of Rs 8,741.08 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 15.51x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -101.8% and ROCE of -78.71%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -12.47, book value per share of Rs 19.71, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 15.51x |
| Benchmark Median P/B | 2.98x |
| Benchmark Average P/B | 4.31x |
| Company ROE | -101.8% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | -78.71% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 8,741.08 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
| Benchmark Average Market Cap | Rs 14,121.7 crore |
Suven Life Sciences (SUVEN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Suven Life Sciences (SUVEN) has a ROE of -101.8%, which is below the benchmark median of 11.61%, a difference of -976.83%. Suven Life Sciences (SUVEN) has a ROCE of -78.71%, which is below the benchmark median of 13.46%, a difference of -684.77%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,739.76 | 82.14 | 19.96 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,710.44 | 25.51 | 4.27 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
Its ROE of -101.8% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at -78.71% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Suven Life Sciences (SUVEN) has a market capitalisation of Rs 8,741.08 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Suven Life Sciences
- Suven Life Sciences Share Price fell 5.15% today, with the stock last traded at Rs 290.
- Suven Life Sciences Share Price sits near the lower end of the day’s range after opening at Rs 308.75.
- Suven Life Sciences Fundamental Analysis shows P/B at 15.51, far above the same-industry median.
- ROE at -101.8% and ROCE at -78.71% keep the profitability picture under review in Suven Life Sciences Stock News.
- Suven Life Sciences Market Cap of Rs 8,741.08 crore places it in the Mid Cap category and above the industry market-cap median.
About Suven Life Sciences
Suven Life Sciences operates in Healthcare, specifically in Pharmaceuticals & Drugs. Suven Life Sciences Share Price is therefore tied to a business that sits inside a regulated and research-intensive industry, where valuation and profitability metrics often matter as much as the daily price move. The company is identified within the Mid Cap category on the company-size context. In the current Suven Life Sciences Company News frame, the most relevant facts are the sector, industry and market-cap placement rather than any unsupported narrative. Suven Life Sciences Share News today is centered on price performance, while the underlying business context remains anchored to pharmaceuticals and drugs within healthcare.
Track Suven Life Sciences Share Price on Univest
Use Suven Life Sciences (SUVEN) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Track Suven Life Sciences Share Price on Univest for live price updates, valuation ratios, 52-week levels and market insights in one place. Univest also helps readers follow Suven Life Sciences Share Price Today alongside sector comparison, fundamental analysis and company context. If you are monitoring Suven Life Sciences Stock News or Suven Life Sciences Latest News, keeping the share price and key ratios together can help organise the day’s market update.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Suven Life Sciences Share Price falling today?
Ans. Suven Life Sciences Share Price fell 5.15% and last traded at Rs 290. The price move is confirmed in Univest data; a company-specific reason has not been established. The move is therefore best read as a verified price-action event.
What is Suven Life Sciences Share Price today?
Ans. Suven Life Sciences Share Price today was Rs 290. The stock was down Rs 15.75 from the previous close of Rs 305.75, and the day’s range ran from Rs 288.5 to Rs 308.75 during the ongoing session.
What does Suven Life Sciences Share Price show about intraday movement?
Ans. Suven Life Sciences Share Price opened at Rs 308.75, matched the day’s high, and later touched Rs 288.5. That range shows a clear decline from the opening level to the last traded price within the same session.
Is Suven Life Sciences a Mid Cap company?
Ans. Yes. Suven Life Sciences is marked as a Mid Cap company in the company-size context. Its market capitalisation stands at Rs 8,741.08 crore, which is above the same-industry median but below the same-industry average.
How does Suven Life Sciences Share Price compare with sector valuation?
Ans. Suven Life Sciences Share Price is linked to a P/B of 15.51, which is far above the same-industry median of 2.98 and average of 4.31. That makes valuation an important part of the current stock discussion.
What do Suven Life Sciences ROE and ROCE indicate?
Ans. Suven Life Sciences reports ROE of -101.8% and ROCE of -78.71%. Both are below the same-industry medians and averages, so the profitability and capital-return profile remains a key point in Suven Life Sciences Share Price analysis.
What is the book value and EPS for Suven Life Sciences?
Ans. Suven Life Sciences Share Price sits alongside EPS of -12.47 and book value of Rs 19.71. EPS shows earnings attributable to each share, while book value shows accounting net worth behind each share at the current time.
Does Suven Life Sciences pay a dividend?
Ans. The dividend yield is 0%, so Suven Life Sciences Share Price is not accompanied by a current payout yield in the latest Univest figures. That keeps the focus on price action, valuation and profitability rather than income yield.
Should investors track Suven Life Sciences Share Price on Univest?
Ans. Yes. Univest gives a single view of Suven Life Sciences Share Price, valuation ratios, sector context and peer comparison. That makes it easier to follow price movement, fundamental analysis and stock news without losing the broader market setting.
Recent Articles

Infosys Dividend 2026: Rs 26 Per Share Interim Payout, Record Date, Q2 Profit Up 6.23% and What Shareholders Should Know
23 October 2026

Ambit Capital Telecom Picks: Why the Brokerage Backs Airtel, Vodafone Idea and Indus Towers With Buy Ratings and Higher Targets
23 October 2026

Delhi Pollution Curbs: Can They Be a Game-Changer for Auto and EV Stocks From Ather Energy to TMPV?
23 October 2026

Swiggy vs Eternal Shares Compared: Which Is the Better Stock After Q2 FY27 Results as Blinkit Profit Meets Instamart Loss?
23 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Infosys Dividend 2026: Rs 26 Per Share Interim Payout, Record Date, Q2 Profit Up 6.23% and What Shareholders Should Know
Ambit Capital Telecom Picks: Why the Brokerage Backs Airtel, Vodafone Idea and Indus Towers With Buy Ratings and Higher Targets
Delhi Pollution Curbs: Can They Be a Game-Changer for Auto and EV Stocks From Ather Energy to TMPV?
Swiggy vs Eternal Shares Compared: Which Is the Better Stock After Q2 FY27 Results as Blinkit Profit Meets Instamart Loss?
Himadri Speciality Share Price Posts Its Biggest Weekly Fall Since 2008: What Q2 FY27 Margins, Valuation and Guidance Say

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





